Skip to Content

Join the 'Pre-Exposure Prophylaxis' group to help and get support from people like you.

Pre-Exposure Prophylaxis News

Related terms: Pre-Exposure Prophylaxis HIV Infection, PrEP, Reducing Risk of HIV Infection

Charlie Sheen's 2015 HIV Disclosure Spiked Use of Home Test Kits

Posted 10 days ago by Drugs.com

THURSDAY, May 18, 2017 – Soon after actor Charlie Sheen revealed his HIV-positive status back in late 2015, rates of at-home testing for the virus shot up to record levels, a new report shows. The study follows on 2016 research that found the the Internet was abuzz with millions more searches for HIV-related topics after the former "Two and a Half Men" star made the disclosure in November of 2015. In total, all English-language searches about HIV quadrupled beyond the usual number the day after Sheen's announcement, said a team from San Diego State University. Searches for information about HIV symptoms and testing were about six times higher than normal. And their follow-up research has now found that weekly sales of the HIV home-test kit OraQuick nearly doubled in the week after the announcement. "Charlie Sheen's disclosure is potentially the most significant domestic HIV prevention ... Read more

Related support groups: HIV Infection, Valtrex, Acyclovir, Valacyclovir, Ribavirin, Pre-Exposure Prophylaxis, Incivek, Zovirax, Famciclovir, Baraclude, Victrelis, Famvir, Viread, Daklinza, Kaletra, Norvir, Copegus, Entecavir, Ribasphere, Valcyte

Is the AIDS Epidemic Winding Down in the U.S.?

Posted 11 days ago by Drugs.com

WEDNESDAY, May 17, 2017 – Could the United States be turning the corner on the AIDS epidemic? New research suggests it's possible. If certain targets are met, the rate of new infections may be down to 12,000 a year by 2025, which would mark a transition toward the end of the HIV/AIDS epidemic, the researchers said. "Achieving these targets will require a sustained and intensified national commitment to ending the epidemic," said study author Dr. Robert Bonacci, from Brigham and Women's Hospital in Boston. "But if the U.S. does achieve a reduction to 12,000 new HIV infections by 2025, it could mark an important turning point in the U.S. HIV epidemic: a decline in the total number of people living with HIV in the U.S., and the beginning of the end of the U.S. AIDS epidemic," he said in a hospital news release. It's crucial that the goals of the U.S. National HIV/AIDS Strategy (NHAS) are ... Read more

Related support groups: HIV Infection, Pre-Exposure Prophylaxis, Incivek, Baraclude, Victrelis, Viread, Kaletra, Entecavir, Tenofovir, Norvir, Lamivudine, Telaprevir, Nevirapine, Prezista, Boceprevir, Reyataz, Abacavir, Zidovudine, Ritonavir, Tivicay

Life Expectancy With HIV Nears Normal With Treatment

Posted 18 days ago by Drugs.com

WEDNESDAY, May 10, 2017 – Young adults with HIV who get treatment are living longer in North America and Europe, a new study finds. In fact, a 20-year-old with HIV who began antiretroviral treatment in 2008 or later and had a low viral load after a year of treatment has a life expectancy that's close to that of the general population – around 78 years old, the study found. But life expectancy for people with HIV mostly remains lower than that of the general population, according to the study published in The Lancet HIV. The researchers said their findings could help reduce stigmatization of people with HIV and help them get jobs and medical insurance. The study should also encourage newly diagnosed HIV patients to begin treatment as soon as possible and stick with it. "Our research illustrates a success story of how improved HIV treatments coupled with screening, prevention and ... Read more

Related support groups: HIV Infection, Valtrex, Acyclovir, Tamiflu, Valacyclovir, Ribavirin, Pre-Exposure Prophylaxis, Incivek, Zovirax, Famciclovir, Baraclude, Victrelis, Famvir, Oseltamivir, Viread, Kaletra, Norvir, Ribasphere, Copegus, Valcyte

U.S. Sees Big Drop in Number of Babies Born With HIV

Posted 20 Mar 2017 by Drugs.com

MONDAY, March 20, 2017 – The number of infants born with HIV in the United States has dropped dramatically over the past two decades, a new study shows. According to new data from the U.S. Centers for Disease Control and Prevention, there were 69 cases of HIV-infected infants in 2013, compared with 216 cases in 2002. Factors tied to mother-to-child transmission of HIV include late HIV diagnosis of mothers and a lack of antiretroviral and preventive treatment, say a team led by the CDC's Dr. Steven Nesheim. "Missed opportunities for prevention were common among infected infants and their mothers in recent years," they wrote. One HIV expert who reviewed the paper noted other disparities, as well. "More than 80 percent of new cases of mother-to-child transmission of HIV are from mothers who are black/African American and Hispanic/Latino," said Dr. David Rosenthal. He directs the Center ... Read more

Related support groups: Birth Control, Contraception, HIV Infection, Pre-Exposure Prophylaxis

'Immunotherapy' in Monkeys Shows Promise as Long-Term HIV Treatment

Posted 13 Mar 2017 by Drugs.com

MONDAY, March 13, 2017 – Lab experiments with monkeys suggest that "immunotherapy" holds promise as a long-term treatment for HIV, researchers say. Treatment with two anti-HIV antibodies right after infection might help keep the AIDS-causing virus in check for a prolonged period, according to the new study. Despite an arsenal of HIV drugs, effective long-term treatment remains elusive because inactive versions of the virus lie in wait for an opportunity to attack the immune system, said the researchers from Rockefeller University in New York City and the U.S. National Institutes of Health. "This [new] form of therapy can induce potent immunity to HIV, allowing the host to control the infection," said Michel Nussenzweig, head of Rockefeller's laboratory of molecular immunology. "It works by taking advantage of the immune system's natural defenses, similar to what happens in some forms ... Read more

Related support groups: HIV Infection, Pre-Exposure Prophylaxis, Hizentra, RhoGAM, Gamunex, Gammagard, Hepatitis B Immune Globulin, Immune Globulin Intravenous, Privigen, Diagnosis and Investigation, Rhophylac, Synagis, Gamunex-C, Carimune, Vivaglobin, MICRhoGAM, Immune Globulin Subcutaneous, WinRho SDF, Nabi-HB, Rabies Immune Globulin, Human

Gay Men Less Likely to Have Safe Sex Now: Survey

Posted 13 Feb 2017 by Drugs.com

MONDAY, Feb. 13, 2017 – In a sign that powerful new ways to treat and prevent HIV are relaxing attitudes about safer sex, a new survey finds that gay and bisexual men are much less likely to use condoms than they were two decades ago. Men questioned at a Atlanta gay pride event in 2015 – including HIV-positive men – were more likely to say they'd recently had anal sex without a condom compared to men who were questioned at the same event in 2006 and 1997. Although there are signs that the rates of other sexually transmitted infections have increased and the possibility of a drug-resistant strain of the once-deadly virus looms, HIV experts said the condom-less trend may not be as troubling as it appears. "There has been an increase in the understanding that condom-less anal sex is not risky" if men take a drug to prevent HIV infection or take medication if they are already infected, ... Read more

Related support groups: Birth Control, Contraception, Plan B, Emergency Contraception, Mirena, Nexplanon, Depo-Provera, NuvaRing, Provera, Sprintec, Implanon, Ortho Tri-Cyclen, Tri-Sprintec, Microgestin Fe 1/20, Yasmin, Loestrin 24 Fe, Plan B One-Step, Ortho Evra, TriNessa, Mononessa

Black Americans Still Undertreated for HIV

Posted 3 Feb 2017 by Drugs.com

FRIDAY, Feb. 3, 2017 – Although progress has been made, blacks in America are still being hit harder by HIV/AIDS, a new report from the U.S. Centers for Disease Control and Prevention says. The CDC study found that of more than 12,200 black men and women diagnosed with HIV in 2014, nearly 22 percent had progressed to AIDS by the time they were diagnosed. That means diagnosis and treatment is often coming too late. Moreover, among all black Americans with HIV in 2013, only about 54 percent were receiving continuous medical care. Of those getting care, less than half had effectively suppressed the virus. This is far below the National HIV/AIDS Strategy goals of 90 percent of HIV patients in treatment and 80 percent with undetectable HIV by 2020, the study authors noted. "While we have made great progress in HIV prevention among African Americans in recent years, it is clear that we need ... Read more

Related support groups: HIV Infection, Valtrex, Acyclovir, Tamiflu, Valacyclovir, Ribavirin, Pre-Exposure Prophylaxis, Incivek, Zovirax, Truvada, Famciclovir, Baraclude, Victrelis, Famvir, Oseltamivir, Viread, Kaletra, Valcyte, Entecavir, Copegus

Gay Man Infected With HIV Despite Using Preventive Drugs

Posted 1 Feb 2017 by Drugs.com

WEDNESDAY, Feb. 1, 2017 – Doctors report that a gay Canadian man contracted HIV even though he had been taking daily medication to ward off infection. Based on a genetic analysis of the virus, it was determined that the 43-year-old Toronto resident was infected with a strain of HIV that had become resistant to the anti-HIV drug Truvada, said report author Dr. David Knox. He is a doctor with the Maple Leaf Medical Clinic in Toronto. However, HIV experts say this does not mean a completely drug-resistant strain of the virus is on its way, leading to a return of the AIDS crisis of the 1980s and 1990s. "The number of highly resistant strains for Truvada is still very low," said Greg Millett, vice president and director of public policy for amfAR, The Foundation for AIDS Research. "Less than 1 percent of people living with HIV have a highly resistant strain. I do not have a concern that ... Read more

Related support groups: Plan B, Mirena, Nexplanon, Depo-Provera, NuvaRing, Provera, Sprintec, Implanon, Ortho Tri-Cyclen, Tri-Sprintec, Microgestin Fe 1/20, Yasmin, Loestrin 24 Fe, Plan B One-Step, Ortho Evra, TriNessa, Mononessa, Lutera, Ortho Tri-Cyclen Lo, Yaz

Diabetes Risk May Be Higher for HIV-Positive Adults

Posted 31 Jan 2017 by Drugs.com

TUESDAY, Jan. 31, 2017 – People infected with the virus that causes AIDS may be more likely to develop diabetes, new research suggests. In the study, the prevalence of diabetes was almost 4 percent higher among HIV-positive adults than the general population. Researchers examined survey responses of 8,610 HIV-positive participants in the Medical Monitoring Project (MMP). They also analyzed data from about 5,600 people in the general public who took the annual National Health and Nutrition Examination Survey (NHANES). Of the MMP participants, 75 percent were men and nearly 60 percent were aged 45 or older. About 25 percent were obese; about 20 percent also had hepatitis C (HCV); and 90 percent had received antiretroviral therapy within the past year. Of NHANES participants, about half were men aged 45 years and older; 36 percent were obese; and fewer than 2 percent had hepatitis C. The ... Read more

Related support groups: Obesity, Diabetes, Type 2, Metformin, Insulin, Lantus, HIV Infection, Glucophage, Novolog, Glipizide, Humalog, Glyburide, Lantus Solostar, Levemir, Glimepiride, Pre-Exposure Prophylaxis, Incivek, Novolin R, Amaryl, Novolin N, Humulin N

Can HIV Drugs Boost Syphilis Risk?

Posted 17 Jan 2017 by Drugs.com

MONDAY, Jan. 16, 2017 – Gay and bisexual men taking antiretroviral drugs to treat HIV infection may be at increased risk for syphilis, new research contends. Based on a review of available evidence, the investigators concluded that the drugs may boost susceptibility to the bacterium that causes syphilis, although the study did not prove cause-and-effect. The finding might explain why new and repeat cases of syphilis in gay and bisexual men have risen sharply compared to other sexually transmitted infections over the past decade, the researchers wrote. The study team was led by Dr. Michael Rekart, from the University of British Columbia's School of Population and Public Health in Vancouver. The findings were published in the Jan. 16 issue of the journal Sexually Transmitted Infections. The authors of an editorial that accompanied the study said the theory is "intriguing" and "warrants ... Read more

Related support groups: HIV Infection, Sexually Transmitted Diseases, Valtrex, Acyclovir, Tamiflu, Valacyclovir, Ribavirin, Pre-Exposure Prophylaxis, Incivek, Zovirax, Syphilis, Famciclovir, Baraclude, Victrelis, Famvir, Oseltamivir, Viread, Kaletra, Daklinza, Entecavir

HIV May Double Odds of Heart Attack

Posted 22 Dec 2016 by Drugs.com

WEDNESDAY, Dec. 21, 2016 – As people with HIV are living longer, new concerns are cropping up, such as a risk for heart attack up to two times greater than for people without the AIDS-causing virus, a new study reports. Those increased odds are seen even in people whose virus has been suppressed to undetectable levels in the blood with antiretroviral drugs, the researchers said. There are several reasons for this higher risk, said lead researcher Dr. Matthew Feinstein, a cardiology fellow at Northwestern University Feinberg School of Medicine in Chicago. "A key factor appears to be chronic HIV-associated inflammation that persists even when there is no detectable virus in the blood," he said. Feinstein explained that the heart disease and stroke risk is higher "because the virus maintains a reservoir in the body's tissues, driving a chronic inflammatory and immune response that can ... Read more

Related support groups: Heart Attack, HIV Infection, Pre-Exposure Prophylaxis, Myocardial Infarction, Myocardial Infarction - Prophylaxis, Post MI Syndrome, Family History of Myocardial Infarction

Doctors Seeing More HIV Patients With Multidrug Resistance

Posted 1 Dec 2016 by Drugs.com

THURSDAY, Dec. 1, 2016 – A significant number of people with HIV have strains of the AIDS-causing virus that are resistant to both older and newer drugs, researchers report. The researchers looked at 712 HIV patients worldwide whose infection was not controlled by antiretroviral drugs. They found that 16 percent of patients whose infection was resistant to modern drugs had HIV mutations linked with resistance to older drugs called thymidine analogues. Among patients whose HIV had this mutation, 80 percent were also resistant to tenofovir, the main drug in most modern HIV treatment and prevention programs, the researchers reported. The findings were published in the Nov. 30 issue of The Lancet Infectious Diseases journal. "We were very surprised to see that so many people were resistant to both drugs, as we didn't think this was possible," study lead author Ravi Gupta, of University ... Read more

Related support groups: Harvoni, HIV Infection, Atripla, Sovaldi, Pre-Exposure Prophylaxis, Incivek, Truvada, Triumeq, Stribild, Complera, Epclusa, Zepatier, Genvoya, Baraclude, Victrelis, Sofosbuvir, Viread, Kaletra, Viekira Pak, Norvir

Use of Needle Exchange Programs Up Dramatically in 10 Years: CDC

Posted 30 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 30, 2016 – Although there was a significant increase in the use of syringe services programs (SSPs) – more commonly known as needle exchange programs – across the United States over the past decade, many injection drug users don't always use sterile needles, a federal government report says. Previously used needles put drug users at risk for infectious diseases such as HIV and hepatitis B and C, the report noted. Needle exchange programs provide sterile needles and syringes to injection drug users. These programs also refer drug users to prevention, care and treatment services. Researchers from the U.S. Centers for Disease Control and Prevention looked at data from injection drug users in 22 cities with high rates of HIV. In 2015, 54 percent of injection drug users said they used a needle exchange program in the past year. That was up significantly compared to the 36 ... Read more

Related support groups: Opiate Dependence, Hepatitis C, HIV Infection, Drug Dependence, Hepatitis B, Pre-Exposure Prophylaxis, Substance Abuse, Toxic Reactions Incl Drug and Substance Abuse, Hepatitis B Prevention, Exposure to Hepatitis B Virus, Hepatitis B Prophylaxis

Can Time-Release Capsules Replace Daily Pills?

Posted 16 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 16, 2016 – A new type of drug capsule might one day replace the need to take medicines every day, but so far it has only been tested in pigs, researchers report. A capsule that contains a six-armed star containing drugs can remain in the stomach and release its medication over time. That means instead of taking daily medication, patients would only have to swallow one capsule weekly or monthly, the researchers said. "We have the potential for an ultra-long capsule for medications that folks are currently taking once or twice or three times a day – that can now be given once a week or once a month," said researcher Dr. Giovanni Traverso. He is an instructor in the division of gastroenterology at Brigham and Women's Hospital in Boston. "This can make life a lot easier, because patients are more likely to take a medication when it's dosed once a week versus once a day," ... Read more

Related support groups: Schizophrenia, Schizoaffective Disorder, HIV Infection, Renal Failure, Alzheimer's Disease, Pre-Exposure Prophylaxis, Chronic Kidney Disease, Hyperphosphatemia of Renal Failure

Drug Combo Shows Early Promise for Remission of HIV

Posted 10 Nov 2016 by Drugs.com

THURSDAY, Nov. 10, 2016 – Animal research with an experimental two-drug therapy could hold clues for creating long-term HIV remission in people living with the virus, a new report says. The goal: to free patients from the need to take anti-HIV pills each day. Researchers combined an experimental vaccine with an immune-stimulating drug to create a one-two punch that caused a similar virus to become undetectable in three out of nine test monkeys, said senior author Dr. Dan Barouch. He's director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center in Boston. "Both of these components already are in clinical trials being conducted separately," Barouch said. "We hope to evaluate the combination in humans, and we plan to do further animal studies as well. The experimental vaccine, called Ad26/MVA, aims to help the immune system target HIV. The ... Read more

Related support groups: HIV Infection, Pre-Exposure Prophylaxis, Diagnosis and Investigation

Page 1 2 3 4 5 Next

Ask a Question

Further Information

Related Condition Support Groups

HIV Infection

Related Drug Support Groups

Truvada, emtricitabine / tenofovir